BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19836948)

  • 1. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
    McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.
    McLean LR; Zhang Y; Li H; Choi YM; Han Z; Vaz RJ; Li Y
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1821-4. PubMed ID: 20185308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
    Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
    Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
    Garai J; Molnár V; Eros D; Orfi L; Lóránd T
    Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
    Cheng KF; Al-Abed Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
    El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
    Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irregularities in enzyme assays: The case of macrophage migration inhibitory factor.
    Cisneros JA; Robertson MJ; Valhondo M; Jorgensen WL
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2764-2767. PubMed ID: 27156768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
    Orita M; Yamamoto S; Katayama N; Fujita S
    Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.
    Orita M; Yamamoto S; Katayama N; Aoki M; Takayama K; Yamagiwa Y; Seki N; Suzuki H; Kurihara H; Sakashita H; Takeuchi M; Fujita S; Yamada T; Tanaka A
    J Med Chem; 2001 Feb; 44(4):540-7. PubMed ID: 11170644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures.
    McLean LR; Zhang Y; Degnen W; Peppard J; Cabel D; Zou C; Tsay JT; Subramaniam A; Vaz RJ; Li Y
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1981-4. PubMed ID: 20153645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
    Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
    Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoate.
    Golubkov PA; Johnson WH; Czerwinski RM; Person MD; Wang SC; Whitman CP; Hackert ML
    Bioorg Chem; 2006 Aug; 34(4):183-99. PubMed ID: 16780921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
    Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
    Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor.
    Dziedzic P; Cisneros JA; Robertson MJ; Hare AA; Danford NE; Baxter RH; Jorgensen WL
    J Am Chem Soc; 2015 Mar; 137(8):2996-3003. PubMed ID: 25697265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationships and Anti-inflammatory Activities of N-Carbamothioylformamide Analogues as MIF Tautomerase Inhibitors.
    Zhang Y; Xu L; Zhang Z; Zhang Z; Zheng L; Li D; Li Y; Liu F; Yu K; Hou T; Zhen X
    J Chem Inf Model; 2015 Sep; 55(9):1994-2004. PubMed ID: 26288111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
    Garai J; Lóránd T
    Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
    Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
    Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.